Broughton celebrates Premarket Tobacco Product Application (PMTA) success for clients.
Broughton's Chief Scientific and Regulatory Officer Dr. Nveed Chaudhary discusses the recent FDA announcement on marketing orders and what ...
Broughton's Chief Scientific and Regulatory Officer Dr. Nveed Chaudhary discusses how England is leading the way internationally in terms ...
Broughton's Chief Scientific and Regulatory Officer, Dr Nveed Chaudhary discusses what developments are expected over the next 12 months ...
Broughton's Head of Regulatory Affairs, Lloyd Smart, and Regulatory Consultant, Xiangyin Wei summarise China's Tobacco Monopoly Law Changes ...
Broughton's Head of Regulatory Affairs, Lloyd Smart has recently published an article with the leading sector publication Tobacco Reporter.
Broughton's Chief Scientific Officer, Chris Allen shares his opinion with Financial Times about e-cigarettes on the NHS.
Broughton's Head of Regulatory Affairs, Lloyd Smart discusses the latest UK Medicines & Healthcare products Regulatory Agency (MHRA) ...
Broughton's Head of Regulatory Affairs, Lloyd Smart discusses Food and Drug Administration (FDA) final ruling for Premarket Tobacco Product ...
Broughton's Head of Regulatory Affairs, Lloyd Smart discusses the Australian Government's recent announcement regarding existing nicotine ...
Broughton Director of Product Safety and Compliance, Yvonne Wilding, discusses implications of Brexit on the international ENDS market.
Broughton is delighted to announce that Paul Hardman joins as Head of Scientific Affairs. This latest appointment further bolsters the ...
Broughton Chief Regulatory Officer, Dr Nveed Chaudhary shares his thoughts on the latest FDA announcement, ‘Clarification on General ...
Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary to present the future challenges of the ENDS regulatory battleground and the ...
Broughton Chief Regulatory Officer, Dr Nveed Chaudhary announces the launch of our Blue-sky thinking hub aimed at nicotine, pharmaceutical, ...
Broughton Dr Nveed Chaudhary, Chief Regulatory Officer discusses the EU's stance on Next Generation Products and what this means for ...
Broughton Dr Nveed Chaudhary, Chief Regulatory Officer, discusses Deficiency Letters and data gap fulfillment and why the time to act is ...
Broughton Regulatory Operations Manager, Emily Saunders, discusses FDAs announcement on the final ruling for PMTA applications.
Broughton Director of Product Safety and Compliance, Yvonne Wilding, discusses a leading-edge software tool designed and in use at ...
Broughton Chief Scientific Officer, Chris Allen, discusses the sensitivity of analytical methods appropriate for Toxicological assessment ...
Broughton, Director of Product Safety and Compliance, Yvonne Wilding and Principal Scientist, Louise Neilson will be in attendance and ...
Broughton Director of Product Safety and Compliance, Yvonne Wilding, looks at the recent Tobacco Product Perception and Intention studies ...
Broughton , Director of Product Safety and Compliance, Yvonne Wilding has recently published an article with leading sector publication ...
Emily Saunders, Regulatory Operations Manager, takes a look at the potential delay to the Tobacco Product Directive (TPD3) and the future ...
Broughton announce, Chief Scientific Officer to join panel discussion at GTNF 2020
Broughton, Senior Project Scientist, will participate in a webinar hosted by Separation Science, sponsored by Thermo Fisher Scientific.
As the September 9th, 2020 PMTA deadline rapidly approaches, our Chief Scientific Officer, Chris Allen, takes a look at the current US ...
Broughton are pleased to take part in Thermo Fisher Scientific’s video series - Charlie Chats.
Broughton announce new webinar.
In silico methods for the prediction of toxicity are becoming more widely used in the field of toxicology.
Broughton, Marketing Manager discusses changing times, virtual events and embracing technology.
This article provides an overview of the different types of toxicological studies typically undertaken, and how they support regulatory ...
Broughton announce expansion of Toxicology team directed by Yvonne Wilding.
Extension of the Premarket Tobacco Product Application (PMTA) deadline, requested by the US Food and Drug Administration (FDA) due to the ...
A recent announcement from The Food and Drug Administration (FDA) on the Premarket Tobacco Authorization (PMTA) final ruling means that the ...
The US Food and Drug Administration (FDA) has requested an extension to the Premarket Tobacco Product Application (PMTA) deadline due to ...
We’re delighted to announce that Broughton has launched an in-house toxicology services division to increase our capacity and introduce ...
Alan Hutchinson, Principal Scientist at Broughton, has recently published an article with Laboratory News; the leading magazine for UK ...
Are you confused by the ENDS flavor debate? Dr. Ian Fearon, Broughton subject matter expert for clinical studies, has recently published an ...
The US Food and Drug Administration (FDA) has published final guidance regarding Enforcement Priorities for Electronic Nicotine Delivery ...
We’re delighted to announce that Broughton has recently launched an in-house service focused on enabling companies in the Electronic ...
We are delighted to announce that Broughton has made a series of major business transactions to meet the demands of our growing portfolio.
The US Food and Drug Administration (FDA) recently published a “Proposed Rule” for the Electronic Nicotine Delivery Systems (ENDS) sector. ...
Save the date. Monday 22nd October is looking like a key day for the US ENDS industry.
Electronic cigarettes are battery powered electronic devices that enable delivery of nicotine to a user without the combustion processes of ...
Last week we attended the Vape and the FDA event hosted by the Vapor Technology Association (VTA) in Washington DC. It was great to catch ...
Maintaining regulatory compliance is a key factor in keeping your Electronic Nicotine Delivery System (ENDS) products on the market. A ...